A detailed history of Fieldpoint Private Securities, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 517 shares of AMGN stock, worth $163,134. This represents 0.04% of its overall portfolio holdings.

Number of Shares
517
Previous 2,435 78.77%
Holding current value
$163,134
Previous $589,000 78.61%
% of portfolio
0.04%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $442,501 - $492,427
-1,918 Reduced 78.77%
517 $126,000
Q1 2022

Apr 07, 2022

SELL
$219.27 - $242.57 $128,711 - $142,388
-587 Reduced 19.42%
2,435 $589,000
Q4 2021

Jan 24, 2022

SELL
$198.88 - $227.6 $104,610 - $119,717
-526 Reduced 14.83%
3,022 $680,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $3,608 - $4,227
-17 Reduced 0.48%
3,548 $754,000
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $192,236 - $213,272
-823 Reduced 18.76%
3,565 $813,000
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $119,165 - $138,868
537 Added 13.94%
4,388 $1.09 Million
Q4 2020

Jan 28, 2021

SELL
$216.38 - $257.67 $55,176 - $65,705
-255 Reduced 6.21%
3,851 $885,000
Q3 2020

Oct 23, 2020

BUY
$234.65 - $260.95 $93,156 - $103,597
397 Added 10.7%
4,106 $1.04 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $733,677 - $900,322
3,709 New
3,709 $875,000
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $36,083 - $47,856
-198 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $3,216 - $4,134
17 Added 9.39%
198 $48,000
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $95,852 - $112,360
-575 Reduced 76.06%
181 $33,000
Q2 2018

Aug 06, 2018

BUY
$166.05 - $186.51 $9,132 - $10,258
55 Added 7.85%
756 $140,000
Q4 2017

Feb 15, 2018

SELL
$168.79 - $188.59 $251,665 - $281,187
-1,491 Reduced 68.02%
701 $122,000
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $249,429 - $284,781
1,491 Added 212.7%
2,192 $409,000
Q2 2017

Aug 14, 2017

BUY
N/A
701
701 $121,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.